India and the European Union have reportedly hit a snag in their long-running negotiations over a free trade agreement, hoped to boost bilateral trade by nearly $30 billion. Initially slated for signature in early April, the agreement now appears to have been postponed until 2012. One of the key sticking points in the negotiations is a proposal to enhance intellectual property protections for medicine. India has a thriving generic drug industry. It did not allow patents on pharmaceutical products until 2005, when it adapted its laws to conform with the World Trade Organization’s intellectual property rules. Products produced prior to […]
Keep reading for free right now!
Get instant access to the rest of this article as well as three free articles per month. You'll also receive our free email newsletter to stay up to date on all our coverage:
Or, Subscribe now to get full access.
Already a subscriber? Log in here .
What you’ll get with an All-Access subscription to World Politics Review:
A WPR subscription is like no other resource — it’s like having your own personal researcher and analyst for news and events around the globe. Subscribe now, and you’ll get:
- Immediate and instant access to the full searchable library of 15,000+ articles
- Daily articles with original analysis, written by leading topic experts, delivered to you every weekday
- Weekly in-depth reports on important issues and countries
- Daily links to must-read news, analysis, and opinion from top sources around the globe, curated by our keen-eyed team of editors
- Your choice of weekly region-specific newsletters, delivered to your inbox.
- Smartphone- and tablet-friendly website.
- Completely ad-free reading.
And all of this is available to you when you subscribe today.